Histological improvement of chronic liver disease after spontaneous serum hepatitis C virus clearance

Journal of Medical Virology

Volumn 69, Issue 1, 2003, Pages 41-49

  Sugiyasu, Yasunori ^a   Yuki, Nobukazu ^a   Nagaoka, Takayuki ^b   Yamashiro, Masatoshi ^b   Kawahara, Kunimitsu ^a   Iyoda, Kenya ^a   Kakiuchi, Yoshimi ^a   Kaneko, Akira ^a   Yamamoto, Keiji ^a   Hikiji, Kazumasa ^b   Kato, Michio ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b SRL INC   (Japan)

Author keywords

HCV antibody; HCV RNA; Hepatitis C

Indexed keywords

COMPLEMENTARY DNA; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; VIRUS HEPATITIS; VIRUS LOAD;

FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS;

EID: 0037211819     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10250     Document Type: Article

References (16)

1. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M, Kohara M. 1999. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37:2899-2903.
2. Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J. 1999. Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 29:1288-1298.
3. Diodati G, Bonetti P, Noventa F, Casarin C, Rugge M, Scaccabarozzi S, Tagger A, Pollice L, Tremolada F, Davite C, Realdi G, Ruol A. 1994. Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial. Hepatology 19:1-5.
4. Dries V, von Both I, Muller M, Gerken G, Schirmacher P, Odenthal M, Bartenschlager R, Drebber U, zum Buschenfelde KHM, Dienes HP. 1999. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 29:223-229.
5. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. 1993. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 104:877-883.
6. Haydon GH, Jarvis LM, Blair CS, Simmonds P, Harrison DJ, Simpson KJ, Hayes PC. 1998. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 42:570-575.
7. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wallman J. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
8. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
9. Lau DTY, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 1998. 10-Year follow-up after interferon-α therapy for chronic hepatitis C. Hepatology 28:1121-1127.
10. Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S. 1997. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy. Ann Intern Med 127:875-881.
11. Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Cerutti E, Di Napoli A, Solinas A, Deplano A, Tocco A, Cossu P, Chien D, Kuo G, Polito A, Weiner AJ, Houghton M, Verme G, Bonino P, Rizzetto M. 1993. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b. Hepatology 18:1300-1305.
12. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita I, Onishi E, Andoh T, Yoshida I, Okayama H. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105-1113.
13. Tomimatsu M, Endou H, Takahashi H, Iga D, Kato Y, Tamai N, Nakajima H, Okano A, Mori H, Hisatomi H. 1997. Negative strand of hepatitis C virus RNA in the liver of patients with chronic hepatitis C after interferon treatment. J Gastroenterol Hepatol 12:629-632.
14. Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, Langer B, Meisner H, Hess J. 1999. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341:866-870.
15. Yuki N, Hayashi N, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T. 1993a. Changes in antibodies to specific hepatitis C virus antigens with interferon-α therapy: Analysis by recombinant immunoblot assay. Am J Gastroenterol 88:914-918.
16. Yuki N, Hayashi N, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T. 1993b. Quantitative analysis of antibodies to hepatitis C virus during interferon-a therapy. Hepatology 17:960-965.